Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
kinase inhibitor
Biotech
Incyte vets raise $102M to create better PARP, PI3K drugs
A group of familiar faces to Incyte watchers has broken off to create competitors to approved cancer drugs from AstraZeneca, GSK, Novartis and Pfizer.
Nick Paul Taylor
Jan 24, 2024 8:38am
Roche’s breast cancer drug hits primary endpoint in phase 3
Dec 5, 2023 4:12am
BeiGene offers up $1.3B in biobucks for preclinical cancer drug
Nov 21, 2023 7:13am
Roche pays $70M for HER2 breast cancer brain metastases prospect
May 9, 2023 6:30am
Aditum finds twist on old idea, paying $10M for BTK inhibitor
Apr 28, 2023 6:11am
Gossamer halts work on BTK inhibitor after 2 patient deaths
Apr 4, 2023 4:30am
